De Young & Hayden, LLC., a newly formed biopharmaceutical consulting company, announced Monday that it is open for business. The focus of the new enterprise is on helping new and established biotechs and pharmaceutical companies bring new therapies to market. According to founding partner Larry De Young, Ph. D., “What we bring to the table is an informed and knowledgeable objective point of view as well as many years of hands-on experience to integrate preclinical and clinical science with the realities of the market place.”
